Raffles Medical Group Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported revenue of SGD 120,189,000 against SGD 114,915,000 a year ago. Profit from operating activities was SGD 18,891,000 against SGD 18,087,000 a year ago. Profit before tax was SGD 18,857,000 against SGD 18,269,000 a year ago. Profit for the period was SGD 15,466,000 against SGD 14,965,000 a year ago. Profit attributable to owners of the company was SGD 15,812,000 against SGD 15,545,000 a year ago. Net cash from operating activities was SGD 23,962,000 against SGD 18,175,000 a year ago. Acquisition of intangible assets was SGD 211,000. Purchase of property, plant and equipment was SGD 4,110,000 against SGD 1,411,000 a year ago. Diluted earnings per share were 0.89 cents against 0.88 cents a year ago. The group's net profit after tax attributable to owners of the company recorded an increase of 1.7%, this was mainly attributed to the increase in revenue offset by higher expenditure in inventories, depreciation and staff costs due to the expansion of medical centres and beds to meet growing patients' demands. EBITDA was SGD 23,267,000 against SGD 21,765,000 a year ago.

For the first quarter, the company reported property, plant and equipment written off of SGD 45,000 against SGD 33,000 a year ago.

Based on the current economic outlook and barring unforeseen circumstances, the Directors expects the group to grow and remain profitable in 2018.